Mathematical Modeling and Analysis of MDR-TB with Vaccination and Re-infection
DOI:
https://doi.org/10.62054/ijdm/0302.25Abstract
Tuberculosis (TB) is still one of the major infectious diseases in the world and a leading public health problem, particularly in developing countries where multidrug-resistant tuberculosis (MDR-TB) seriously threatens the efforts to control it. A deterministic compartmental model is developed to study TB transmission dynamics with vaccination, reinfection, treatment failure and development of MDR-TB. The total human population is stratified into six disjoint classes: susceptible unvaccinated, susceptible vaccinated, exposed, infectious with drug-susceptible TB, infectious with MDR-TB, and recovered individuals. The positivity and boundedness of solutions are proved to ensure biological feasibility of the qualitative properties of the model. We obtain the disease-free and endemic equilibrium states and calculate the basic reproduction number $\mathcal{R}_0$ using the next-generation matrix method. The stability analysis reveals that the disease-free equilibrium is locally and globally asymptotically stable if $\mathcal{R}_0 < 1$, and unstable if $\mathcal{R}_0 > 1$. Furthermore, by developing a suitable Lyapunov function and using LaSalle's invariance principle, the global asymptotic stability of the endemic equilibrium is established for $\mathcal{R}_0>1$. Numerical simulations are performed to illustrate the effects of critical epidemiological parameters on the disease progression and to verify the analytical results. Sensitivity analysis based on Partial Rank Correlation Coefficients (PRCC) shows that the effective contact rate is the most critical parameter influencing TB transmission, while the treatment and recovery parameters play a strong role in reducing the spread of the disease. The study shows that effective vaccination, better treatment adherence and strong MDR-TB case management are necessary to cut down TB burden and attain long-term control over the disease
References
begin{thebibliography}{999}
bibitem[European Centre for Disease Prevention and Control(2024)]{ecdc_tbb}
European Centre for Disease Prevention and Control (ECDC). (2024). Tuberculosis surveillance and monitoring in Europe: Bulgaria country data. Retrieved April 21, 2026, from url{https://www.ecdc.europa.eu/en/tuberculosis}
bibitem[Bagcchi(2023)]{bagc2023tb}
Bagcchi, S. (2023). WHO's Global Tuberculosis Report 2022. textit{The Lancet Microbe}, textit{4}(1), e20. url{https://doi.org/10.1016/S2666-5247(23)00002-2}
bibitem[World Health Organization(2022)]{who2022tb}
World Health Organization. (2022). textit{Global Tuberculosis Report 2022}. World Health Organization. url{https://www.who.int/teams/global-tuberculosis-programme/tb-reports}
bibitem[Abdullahi et al.(2024)]{abdullahi2023rabies}
Abdullahi, M.; Musa, S.; Husseini, A.; Song, M.I. (2024). Dynamics of Rabies Transmission Model in Human and Dog Populations with Time Delay. textit{International Journal of Development Mathematics}, textit{1}(1), 1--15. url{https://doi.org/10.62054/ijdm/0101.10}
bibitem[Abdullahi et al.(2019)]{abdullahi2019tb}
Abdullahi, M.; Momoh, A.A.; Abdullahi, S.A.; Edogbanya, H.O. (2019). A Mathematical Model of Tuberculosis with Passive Immunity and Drug Resistance Effects. textit{International Journal of Science for Global Sustainability}, textit{5}(1), 72--83. url{https://doi.org/10.57233/ijsgs.v5i1.248}
bibitem[Peter and Mark(2005)]{peter2005bcg}
Peter, A.; Mark, T.D. (2005). The success and failure of BCG—Implications for a novel tuberculosis vaccine. textit{Nature Reviews Microbiology}, textit{3}, 656--662. url{https://doi.org/10.1038/nrmicro1211}
bibitem[Nadolinskaia et al.(2020)]{nadolinskaia2020tb}
Nadolinskaia, I.N.; Karpov, S.D.; Goncharenko, V.A. (2020). Vaccines against tuberculosis: Problems and prospects (Review). textit{Biochemistry (Moscow)}, textit{56}(5), 497--504. url{https://doi.org/10.1134/S0006297920050068}
bibitem[World Health Organization(2023)]{WHO2023}
World Health Organization. (2023). textit{Global Tuberculosis Report 2023}. World Health Organization. url{https://www.who.int/teams/global-tuberculosis-programme/tb-reports}
bibitem[Verver et al.(2005)]{verver2005}
Verver, S.; Warren, R.M.; Beyers, N.; Richardson, M.; van der Spuy, G.D.; Borgdorff, M.W.; Enarson, D.A.; Behr, M.A.; van Helden, P.D. (2005). Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. textit{American Journal of Respiratory and Critical Care Medicine}, textit{171}, 1430--1435. url{https://doi.org/10.1164/rccm.200409-1200OC}.
bibitem[Alhassan et al.(2024)]{alhassan2024corruption}
Alhassan, A.; Momoh, A.; Abdullahi Ahijo, S.; Abdullahi, M. (2024). Mathematical Model on The Dynamics of Corruption Menace with Control Strategies. textit{International Journal of Science for Global Sustainability}, textit{10}(1), 142--153. url{https://doi.org/10.57233/ijsgs.v10i1.604}.
bibitem[Gabriela et al.(2007)]{gabriela2007tb}
Gabriela, M.G.; Paula, R.; Frank, M.H.; Natalia, B.M.; Marion, M.; Graham, F.M. (2007). Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions. textit{Journal of Theoretical Biology}, textit{248}, 608--617. url{https://doi.org/10.1016/j.jtbi.2007.05.002}
bibitem[Abimbode et al.(2020)]{abimbode2020tb}
Abimbode, S.F.; Olaniyi, O.; Ajala, A.; Ibrahim, M.O. (2020). Optimal control analysis of a tuberculosis model. textit{Optimal Control Applications and Methods}, textit{41}(3), 1--20. url{https://doi.org/10.1002/oca.2581}
bibitem[Yongqi et al.(2011)]{yongqi2011tb}
Yongqi, L.; Zhendong, S.; Guiquan, S.; Qiu, Z.; Li, J.; Lin, Z.; et al. (2011). Modeling transmission of tuberculosis with MDR and undetected cases. textit{Discrete Dynamics in Nature and Society}, textit{2011}, 1--12. url{https://doi.org/10.1155/2011/874986}
bibitem[Christopher(2006)]{christopher2006hivtb}
Christopher, D. (2006). HIV/AIDS, tuberculosis and malaria. textit{The Lancet}, textit{367}, 938--940. url{https://doi.org/10.1016/S0140-6736(06)68347-9}
bibitem[Elbasha and Gumel(2006)]{elbasha2006hivvaccine}
Elbasha, E.H.; Gumel, A.B. (2006). Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits. textit{Bulletin of Mathematical Biology}, textit{68}, 577--614. url{https://doi.org/10.1007/s11538-005-9017-7}
bibitem[Brauer and Castillo-Chavez(2000)]{brauer2000mathmodels}
Brauer, F.; Castillo-Chavez, C. (2000). textit{Mathematical Models in Population Biology and Epidemiology}. Texts in Applied Mathematics, Vol. 40. Springer: New York.
bibitem[Bimal and Jyohka(2014)]{bimal2014}
Bimal, K.M.; Jyohka, S. (2014). Mathematical model on pulmonary and multidrug-resistant tuberculosis patients with vaccination. textit{Journal of the Egyptian Mathematical Society}, textit{22}, 311--316.
bibitem[Van den Driessche and Watmough(2002)]{VanDenDriessche2002}
Van den Driessche, P.; Watmough, J. (2002). Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. textit{Mathematical Biosciences}, textit{180}(1-2), 29--48. url{https://doi.org/10.1016/S0025-5564(02)00108-6}
bibitem[Ayinla and Wan Ainun(2019)]{ayinla2019}
Ayinla, A.Y.; Wan Ainun, M. (2019). A compartmental model on the effect of quarantine on MDR-TB. textit{International Journal of Mathematics and Computer Science}, textit{14}(3), 613--629.
bibitem[Dheda et al.(2016)]{dheda2016}
Dheda, K.; Gumbo, T.; Maartens, G.; Dooley, K.E.; McNerney, R.; Murray, M.; Furin, J.; Nardell, E.A.; London, L.; Lessem, E.; Theron, G. (2016). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and extensively drug-resistant tuberculosis. textit{The Lancet Respiratory Medicine}, textit{4}(4), 291--360. url{https://doi.org/10.1016/S2213-2600(16)00055-6}
end{thebibliography}
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Musa Abdullahi, Adamu M. Alkali, Ismaila M. Songb, Abdullahi, S. Aliero (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are solely responsible for obtaining permission to reproduce any copyrighted material contained in the manuscript as submitted. Any instance of possible prior publication in any form must be disclosed at the time the manuscript is submitted and a
copy or link to the publication must be provided.
The Journal articles are open access and are distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs 4.0 IGO License, which permits use,
distribution, and reproduction in any medium, provided the original work is properly cited.
No modifications or commercial use of the articles are permitted.




